Lumida
/VTR
⌘K
Ventas Inc

Ventas Inc

VTR
$89.99USD-0.50%-0.45 today

MARKET CAP

46.2B

P/E (TTM)

164.4x

FWD P/E

112.0x

DAY RANGE

$90 – $91

52W RANGE

$67
$102

AI Summary

Stalk
Sell NowMedium

VTR shows a classic Stage 3 distribution reinforced by a Support Failure breaking key lows and declining EMAs. Medium-term bias is bearish, with secondary Post-Parabola Collapse signaling heavy overhead supply and ongoing speculative unwind. Short-term conditions favor selling now on rallies into the declining 9/20/50 EMA cluster. Only a decisive reclaim and sustained acceptance above these EMAs and prior support zone would invalidate this bearish stance.

  • Normalized FFO grew 10% YoY in Q1 2026.
  • Same-store SHOP NOI jumped 15% YoY; revenue +8% with 300 bps occupancy gain.
  • Negative earnings yield indicates potential overvaluation versus earnings.
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

Ventas, Inc. (NYSE: VTR) is a leading real estate investment trust (REIT) that specializes in senior housing and healthcare properties. With a distinct focus on capitalizing on the increasing demand driven by a rapidly aging population, Ventas operates a diverse portfolio that includes senior living communities, outpatient medical facilities, and research centers. The company's operational strategy is premised on a strong emphasis on enhancing its existing properties while pursuing targeted acquisitions, positioning it favorably in the longevity economy.

Bull says

  • Normalized FFO grew 10% YoY in Q1 2026.
  • Same-store SHOP NOI jumped 15% YoY; revenue +8% with 300 bps occupancy gain.
  • 2.27% dividend yield, increased 8%, supported by a 57% payout ratio.
  • $4.5 B capex planned for 2026 to fund strategic acquisitions.
  • Over-80 demographic set to rise 28% over next five years.
  • Low volatility and strong momentum factors suggest stable outperformance.

Bear says

  • Negative earnings yield indicates potential overvaluation versus earnings.
  • Profitability weakness poses risks to operational efficiency and cost control.
  • High sensitivity to interest rates may elevate borrowing costs.
  • Operating expenses rose 5% YoY, pressuring margins amid inflation.
  • Competition for acquisitions intensifying, potentially lowering future deal returns.
  • Financial health metrics show vulnerabilities that may limit flexibility.

Investment themes with VTR

Nuclear -0.50%

Nuclear energy production and related companies

WELL · PLD · EQIX
Demographics: Elderly Care -0.50%

Services and products for aging population

UCB.BR · JNJ · AZN
Residential REITs -1.05%

Stable income from diversified rental housing portfolios

WELL · PSA · VTR

Earnings Call · Q2 2025 · Mgmt. Guidance

Updated 08-19-2026bullish

Transcript signals

Bull points

  • pleased to report strong earnings growth and again, raise our guidance as we execute our one, two, three strategy.
  • Year over year normalized FFO per share grew 9% and total company same store cash net operating income or NOI increased 7%.
  • raised our full year normalized FFO guidance midpoint to $3.44 per share representing 8% accelerating year over year FFO per share growth at the midpoint.

Bear points

  • Dilutive dispositions of non-strategic post-acute assets in the second quarter are approximately a penny FFO headwind per quarter sequentially versus the second.
Read full transcript analysis ›